Cargando…

Use of misoprostol in the treatment of postpartum hemorrhage: a pharmacoepidemiological approach

OBJECTIVE: To characterize the use of the drug misoprostol for treatment of postpartum hemorrhage in pregnant women. METHODS: A descriptive observational study was carried out with secondary data from pregnant women who used misoprostol to treat postpartum hemorrhage in a reference public maternity,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koch, Daeska Marcella, Rattmann, Yanna Dantas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896658/ https://www.ncbi.nlm.nih.gov/pubmed/31721897 http://dx.doi.org/10.31744/einstein_journal/2020AO5029

Ejemplares similares

Efficacy of Rectal Misoprostol for Prevention of Postpartum Hemorrhage
por: Mirteimouri, Masoumeh, et al.
Publicado: (2013)

Safety and Efficacy of Misoprostol versus Oxytocin for the Prevention of Postpartum Hemorrhage
por: Rajaei, Minoo, et al.
Publicado: (2014)

Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention
por: Prata, Ndola, et al.
Publicado: (2014)

Misoprostol for Prevention of Postpartum Hemorrhage at Home Birth in Afghanistan: Program Expansion Experience
por: Haver, Jaime, et al.
Publicado: (2016)

Efficacy of misoprostol for the treatment of postpartum hemorrhage: current knowledge and implications for health care planning
por: Prata, Ndola, et al.
Publicado: (2016)

Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2015)

Dose and side effects of sublingual misoprostol for treatment of postpartum hemorrhage: what difference do they make?
por: León, Wilfrido, et al.
Publicado: (2012)

Correction: Potential Cost-Effectiveness of Prenatal Distribution of Misoprostol for Prevention of Postpartum Hemorrhage in Uganda
por: Lubinga, Solomon J., et al.
Publicado: (2016)

Virologic success under antiretroviral therapy among people living with HIV/AIDS in the state of Paraná, Brazil
por: Dias, Frederico Alves, et al.
Publicado: (2021)

Misoprostol in addition to routine treatment of postpartum hemorrhage: A hospital-based randomized-controlled trial in Karachi, Pakistan
por: Zuberi, Nadeem F, et al.
Publicado: (2008)

Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date
por: Smith, Jeffrey Michael, et al.
Publicado: (2013)

Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia
por: Smith, Jeffrey Michael, et al.
Publicado: (2014)

Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Xu, Renmei, et al.
Publicado: (2022)

Comparison effect of intravenous tranexamic acid and misoprostol for postpartum haemorrhage
por: Sahhaf, Farnaz, et al.
Publicado: (2014)

Antiretroviral drug use by individuals living with HIV/AIDS and compliance with the Clinical Protocol and Therapy Guidelines
por: Brojan, Lucas Eduardo Fedaracz, et al.
Publicado: (2020)

Clinical guidelines—the challenges and opportunities: What we have learned from the case of misoprostol for postpartum hemorrhage
por: Morris, Jessica L., et al.
Publicado: (2018)

High fever following postpartum administration of sublingual misoprostol
por: Durocher, J, et al.
Publicado: (2010)

Misoprostol for the prevention of postpartum hemorrhage during home births in rural Lao PDR: establishing a pilot program for community distribution
por: Durham, Jo, et al.
Publicado: (2018)

The effect of carbetocin compared to misoprostol in management of the third stage of labor and prevention of postpartum hemorrhage: a systematic review
por: Abd El Aziz, Mohamed A., et al.
Publicado: (2018)

Optimal dose of misoprostol combined with oxytocin for preventing postpartum hemorrhage in cesarean section: A randomised controlled trial
por: Sringamwong, Wirawan, et al.
Publicado: (2022)

Retracted: Comparison of Clinical Efficacy and Safety between Misoprostol and Oxytocin in the Prevention of Postpartum Hemorrhage: A Meta-Analysis
por: Healthcare Engineering, Journal of
Publicado: (2023)

Scaling Up Misoprostol to Prevent Postpartum Hemorrhage at Home Births in Mozambique: A Case Study Applying the ExpandNet/WHO Framework
por: Hobday, Karen, et al.
Publicado: (2019)

Legal demands of the tiotropium bromide for treatment of chronic obstructive pulmonary disease and their financial impact for the State of Paraná, Brazil
por: Szpak, Renata, et al.
Publicado: (2019)

Pharmacovigilance and Pharmacoepidemiology
Publicado: (2008)

Understanding pharmacoepidemiology
Publicado: (2011)

Pharmacoepidemiology: An Overview
por: Sabaté, Mònica, et al.
Publicado: (2023)

Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage
por: Zgaya, Rym, et al.
Publicado: (2020)

Sublingual Misoprostol versus Intramuscular Oxytocin for Prevention of Postpartum Hemorrhage in Uganda: A Double-Blind Randomized Non-Inferiority Trial
por: Atukunda, Esther C., et al.
Publicado: (2014)

Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it?
por: Nasreen, Hashima-E-, et al.
Publicado: (2011)

Using Misoprostol for Primary versus Secondary Prevention of Postpartum Haemorrhage – Do Costs Matter?
por: Chatterjee, Susmita, et al.
Publicado: (2016)

The use of narrative electronic prescribing instructions in pharmacoepidemiology: A scoping review for the International Society for Pharmacoepidemiology
por: Romanelli, Robert J., et al.
Publicado: (2021)

Misoprostol for treating postpartum haemorrhage: a randomized controlled trial [ISRCTN72263357]
por: Hofmeyr, G Justus, et al.
Publicado: (2004)

Prevention of post-partum hemorrhage by rectal Misoprostol: A randomized clinical trial
por: Firouzbakht, Mozhgan, et al.
Publicado: (2013)

Prevention of postpartum haemorrhage: cost consequences analysis of misoprostol in low-resource settings
por: Lang, Danielle L., et al.
Publicado: (2015)

Oxytocin Versus Misoprostol Plus Oxytocin in the Prevention of Postpartum Hemorrhage at a Semi-Urban Hospital in sub-Saharan Africa: A Retrospective Cohort Study
por: Numfor, Emmanuel, et al.
Publicado: (2020)

Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster‐randomised non‐inferiority community trial
por: Raghavan, S, et al.
Publicado: (2016)

Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study
por: Gulati, Sasha, et al.
Publicado: (2018)

Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy
por: Shah, Deepa, et al.
Publicado: (2018)

Foley catheter plus misoprostol versus misoprostol alone for labor induction
por: Elpo, Jhonathan Alcides, et al.
Publicado: (2023)

The Promotion of Data Sharing in Pharmacoepidemiology
por: Sethi, Nayha
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u0fl1mqbhmltpfi8k0t4o9a0j4